Ranbaxy Laboratories has reported results for second quarter ended September 30, 2014.
The company has reported a net loss of Rs 368.26 crore for the quarter under review as compared to a net loss of Rs 842.23 crore for the same quarter in the previous year. Total income of the company has decreased 8.92% at Rs 1338.93 crore for Q2FY15 as compared Rs 1470.19 crore for the corresponding quarter previous year.
On consolidated basis, the company has posted a net profit after taxes and minority interest of Rs 477.76 crore for the quarter as against a net loss of Rs 454.17 crore in the September quarter of previous fiscal. The company’s total income has increased by 15.92% at Rs 3277.88 crore for the quarter from Rs 2827.73 crore in the similar quarter of previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1518.35 |
Dr. Reddys Lab | 6218.90 |
Cipla | 1412.00 |
Zydus Lifesciences | 956.30 |
Lupin | 1659.50 |
View more.. |